Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumors × pazopanib × 30 days × Clear all

Sponsor

Conditions

Sarcoma 3 Carcinoma, Renal Cell 3 Solid Neoplasm 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Perivascular Epithelioid Cell Neoplasms 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Nerve Sheath Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Granuloma, Plasma Cell 1 Fibrosarcoma 1 Dermatofibrosarcoma 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Extraskeletal Myxoid 1

Interventions

pembrolizumab 2 atezolizumab 2 Cetuximab 2 tocilizumab 1 spartalizumab 1 ribociclib 1 pralsetinib 1 olaparib 1 ipatasertib 1 inavolisib 1 entrectinib 1 encorafenib 1 dapagliflozin 1 binimetinib 1 alectinib 1 Trastuzumab 1 Nivolumab 1 Bevacizumab 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡